Lv6
2266 积分 2021-12-21 加入
Immune Phenotype and Response to Neoadjuvant Therapy in Triple-Negative Breast Cancer
10天前
已完结
Spatial Distribution of Immune Cells Drives Resistance to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer
10天前
已完结
Heterogeneity of tertiary lymphoid structures predicts the response to neoadjuvant therapy and immune microenvironment characteristics in triple-negative breast cancer
10天前
已完结
A single dose of peripherally infused EGFRvIII-directed CAR T cells mediates antigen loss and induces adaptive resistance in patients with recurrent glioblastoma
11天前
已完结
Rational development and characterization of humanized anti–EGFR variant III chimeric antigen receptor T cells for glioblastoma
11天前
已完结
Interleukin-7-loaded oncolytic adenovirus improves CAR-T cell therapy for glioblastoma
11天前
已完结
Immunotherapy boosts responses in hormone receptor-positive breast cancers
18天前
已完结
Computational design of synthetic receptors with programmable signalling activity for enhanced cancer T cell therapy
25天前
已完结
Effects of Csf1R-Targeted Chimeric Antigen Receptor-Modified Nk92Mi & T Cells on Tumor-Associated Macrophages
25天前
已完结
Cytokine-induced memory-like natural killer cells exhibit enhanced responses against myeloid leukemia
28天前
已完结
Analysis of phase II and phase III clinical trial terminations from 2013 to 2023
11小时前
待审核
2025 FDA approvals
11小时前
待审核
Open-source protein structure AI aims to match AlphaFold
11小时前
已采纳
AI ‘deepfake’ faces detected using astronomy methods
2天前
已采纳
Upcoming FDA approval decisions in Q1 2026
2天前
已采纳
‘Killswitch’ protein lets scientists study immobilized cellular droplets
2天前
已采纳
First-in-class APRIL inhibitor secures approval for rare kidney disease
2天前
已采纳
Betting on β-catenin inhibitors in oncology
2天前
已采纳
Betting on β-catenin inhibitors in oncology
2天前
已采纳
Betting on β-catenin inhibitors in oncology
2天前
已采纳
皖公网安备34019202002308
